Sivia Capital Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$491K Buy
11,502
+1,786
+18% +$79.8K 0.06% 348
2026
Q1
$468K Buy
9,716
+2,074
+27% +$96.7K 0.09% 271
2025
Q4
$370K Buy
7,642
+1,797
+31% +$89.1K 0.08% 347
2025
Q3
$276K Sell
5,845
-906
-13% -$43.7K 0.08% 353
2025
Q2
$326K Buy
6,751
+347
+5% +$17.7K 0.11% 256
2025
Q1
$355K Buy
6,404
+467
+8% +$25.3K 0.17% 126
2024
Q4
$286K Sell
5,937
-1,128
-16% -$57.4K 0.14% 123
2024
Q3
$407K Sell
7,065
-91
-1% -$4.91K 0.24% 77
2024
Q2
$347K Sell
7,156
-43
-0.6% -$2.07K 0.23% 79
2024
Q1
$350K Buy
7,199
+1,091
+18% +$53.3K 0.24% 83
2023
Q4
$304K Buy
+6,108
New +$299K 0.23% 92

Other funds holding SNY

Sivia Capital Partners's SNY Position: Q2 2026 in Review

Sivia Capital Partners increased its Sanofi (SNY) stake by 18% in Q2 2026, buying an estimated $79.8K and bringing the position to 11,502 shares worth $491K. The position accounts for 0.06% of the portfolio, ranked #348.

Sivia Capital Partners first reported a position in SNY in Q4 2023 and has held it in 11 quarters since. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Sivia Capital Partners held 11,502 shares of Sanofi worth $491K as of Q2 2026.
  • Sivia Capital Partners bought 1,786 Sanofi shares in Q2 2026, an estimated $79.8K.
  • Sanofi made up 0.06% of Sivia Capital Partners's portfolio in Q2 2026, its #348 holding.
  • Sivia Capital Partners first reported a position in Sanofi in Q4 2023 and has held it in 11 quarters since.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.